Back to Journals » Drug Design, Development and Therapy » Volume 15

Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study

Total article views   Abstract views HTML views PDF downloads Totals
1,073 Dovepress* 1,073 0+ 84 1,073
Totals 1,073 0 84 1,073
*Since 3 May 2021
+Since July 2016

View citations on Google Scholar